Company Filing History:
Years Active: 1976-2011
Title: The Innovative Contributions of Michael Sayer
Introduction
Michael Sayer is an esteemed inventor based in Kingston, CA, whose innovative contributions have garnered significant attention in the field of synthetic biomaterials. With a total of 13 patents, he has made notable advancements that have the potential to revolutionize medical treatments and applications.
Latest Patents
Among Sayer's latest patents is the invention of a silicon substituted oxyapatite compound (Si-OAp). This compound serves as a synthetic bone biomaterial, either used alone or in conjunction with other biomaterial compositions. The compound has the formula Ca(PO)(SiO)O, where the range of x varies from 0 to 1.0. Another significant patent focuses on a synthetic biomaterial compound based on stabilized calcium phosphates. This invention includes detailed molecular, structural, and physical characterization, comprising calcium, oxygen, and phosphorous, with at least one element substituted by another possessing an ionic radius between 0.1 to 1.1 Å. The detailed understanding of this compound's molecular and chemical properties allows for the development of various clinical applications in bone-related conditions.
Career Highlights
Michael Sayer's career has been marked by his work with leading companies, including Millennium Biologix Inc. and Warsaw Orthopedic, Inc. His innovative spirit and dedication to research have led to substantial contributions in the biomaterial field, impacting medical practices.
Collaborations
Throughout his career, Sayer has collaborated with notable individuals like Timothy J N Smith and Sydney M Pugh. These partnerships have likely facilitated the exchange of ideas and fostered innovative approaches to biomaterial development.
Conclusion
In conclusion, Michael Sayer's contributions to the field of synthetic biomaterials through his inventive patents demonstrate his significant role as an inventor. His work continues to influence advancements in medical technology and offers promising solutions for various bone-related clinical conditions.